Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Sareum Holdings Plc LSE:SAR London Ordinary Share GB00B02RFS12 ORD 0.025P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.00p +0.00% 0.525p 1,067,765 08:00:00
Bid Price Offer Price High Price Low Price Open Price
0.50p 0.55p 0.525p 0.525p 0.525p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -1.72 -0.05 15.1

Sareum (SAR) Latest News

More Sareum News
Sareum Takeover Rumours

Sareum (SAR) Share Charts

1 Year Sareum Chart

1 Year Sareum Chart

1 Month Sareum Chart

1 Month Sareum Chart

Intraday Sareum Chart

Intraday Sareum Chart

Sareum (SAR) Discussions and Chat

Sareum Forums and Chat

Date Time Title Posts
15/6/201917:42Sareum 2015 3,094
22/8/201719:18Sareum 2016722
12/12/201612:19SAR Sareum Drug Discovery Co.15,853
26/4/201618:292012 Sareum Unleashed4,546
20/4/201609:23SAR news is on its way. fasten your seatbelts!172

Add a New Thread

Sareum (SAR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
08:30:210.53452,6232,398.90O
08:17:320.53281,4281,491.57O
08:03:420.54314,4421,686.98O
07:56:360.5519,272106.00O
View all Sareum trades in real-time

Sareum (SAR) Top Chat Posts

DateSubject
17/6/2019
09:20
Sareum Daily Update: Sareum Holdings Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SAR. The last closing price for Sareum was 0.53p.
Sareum Holdings Plc has a 4 week average price of 0.50p and a 12 week average price of 0.50p.
The 1 year high share price is 0.93p while the 1 year low share price is currently 0.48p.
There are currently 2,875,993,219 shares in issue and the average daily traded volume is 5,107,417 shares. The market capitalisation of Sareum Holdings Plc is £15,098,964.40.
13/6/2019
09:27
yzf750: Not quite ..... SDC-1801 is further advanced and currently demonstrating excellent tolerability with doses up to 30 times the level that gave good responses in efficacy studies; an MTD has yet to be reached. At least I haven't seen this before. We just need the share price to catch up.....
09/6/2019
23:18
cerrito: Does anyone understand what is happening to the Sierra share price if their recent news has been apparently so good?
04/6/2019
00:11
fadec92: The chances of a milestone have just increased and shortened as said by Tim due to the trials being successful and an early route to registration through Anogenital Cancer! looks as if it has strong synergistic quality’s with PD-L1 Immuno-oncology for SCLC (Small Cell Lung Cancer) where it seams PD-L1 on its own dosnt work but pair it with both SRA737 and LDG and it regresses tumors 100% in 21days and a complete response (CR) with 80% cures at day 60, this is exactly the type of treatment that patents need, this will and is a blockbuster, who cares about the share price, market will have to catch up and it will!
03/6/2019
15:05
cerrito: At least SAR share price up; at time of writing, SRA down at US1.04
01/6/2019
16:03
robizm: Dont know how the share price will react Monday though.
11/5/2019
20:05
cerrito: I have been AWOL this week so just now have had the chance to catch up with the Sierra quarterly statement and the 10-Q . More precisely I see that on Page 16 they discuss possible milestone payments and while they mention Gilead and Cama on SRA141, they are silent on our SRA 737. No change then from the equivalent commentary on page 87 of the 10-k as at December 31 2018. This would suggest to me that it is unlikely that we will get any milestones before the need to raise fresh equity after the summer break. This explains the current share price. My reading is that even though we now have a QCA compliant Board of Directors, we have seen no institutional buying-I have just been on the FT website to see their listing of sub 3 pc holders and there seem to be no new faces.
04/4/2019
15:23
nobbygnome: Yes of course every drugs starts in animal models. However, it will be at least 3 years and millions of pounds before you have any clue if the current result translates into humans. Hence no effect on the share price....
25/3/2019
08:08
spacedust: Marten & Co values Sareum’s 27.5% economic interest in SRA737 at £20.3m and places an indicative value on its TYK2 assets of £8-16m, representing a modest upgrade from its previous position. This suggests an overall value for Sareum of £25-35m (0.87-1.14p/share), which offers up to 63% upside to the current share price
27/2/2019
21:42
cerrito: Sierra have just announced quote Sierra Oncology Announces Late-Breaking Oral and Poster Presentations at AACR 2019 for SRA737 and SRA141 Preclinical Data unquote I look forward to Mrs A's insight if this will move the dial for the SAR price. I see that Sierra's share price has had a good last month going up from 1.34 to 1.82 but still way below the 52 week high of 3.70
31/1/2019
17:40
cerrito: I see that the Sierra share price in 1.4 up from 1.3 earlier on the month but way down from the 3 this time last year
Sareum share price data is direct from the London Stock Exchange
Your Recent History
LSE
SAR
Sareum
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190617 10:57:14